Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunosurveillance in clinical cancer management
Guido Kroemer, Timothy A. Chan, Alexander M.M. Eggermont, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 74, Iss. 2, pp. 187-202
Open Access | Times Cited: 51

Showing 26-50 of 51 citing articles:

Immunological aspects of central neurodegeneration
Mireia Niso‐Santano, José M. Fuentes, Lorenzo Galluzzi
Cell Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Generation of transmitochondrial cybrids in cancer cells
Ruth Soler-Agesta, Cristina Ripollés-Yuba, Joaquín Marco-Brualla, et al.
Methods in cell biology (2024), pp. 23-40
Closed Access | Times Cited: 1
Circular RNAs and the JAK/STAT pathway: New frontiers in cancer therapeutics
Waleed Hassan Almalki, Salem Salman Almujri
Pathology - Research and Practice (2024) Vol. 260, pp. 155408-155408
Closed Access | Times Cited: 1
Obesity-Associated Colorectal Cancer
Lucía G. Gutiérrez, Omar Motiño, Daniel Barriuso, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8836-8836
Open Access | Times Cited: 1
Epigenetic control of immunoevasion in cancer stem cells
Claudia Galassi, Manel Esteller, Ilio Vitale, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 1
Benzodiazepines compromise the outcome of cancer immunotherapy
Léa Montégut, Lisa Derosa, Meriem Messaoudene, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
The danger theory of immunity revisited
Guido Kroemer, Léa Montégut, Oliver Kepp, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 912-928
Closed Access | Times Cited: 1
Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors
Elena Catanzaro, Manuel Beltrán‐Visiedo, Lorenzo Galluzzi, et al.
Cellular and Molecular Immunology (2024)
Open Access | Times Cited: 1
Carbon Ion Irradiation Activates Anti-Cancer Immunity
Makoto Sudo, Hiroko Tsutsui, Jiro Fujimoto
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2830-2830
Open Access
Immunogenic oncolysis by tigilanol tiglate
Jonathan Pol, Manuela Lizarralde-Guerrero, Guido Kroemer
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
Bio-inspired Nanomaterials in Cancer Theranostics
Monika Kaushik, Sanjesh Kumar, Mansi Singh, et al.
(2024), pp. 95-123
Closed Access
Targeted opening of the blood–brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma
Jonathan Pol, Manuela Lizarralde-Guerrero, Andrea Checcoli, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
Identifying and validating the roles of the cuproptosis-related gene DKC1 in cancer with a focus on esophageal carcinoma
D D Zhang, Qingwen Zhu, Xu‐Feng Huang, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 8
Open Access
NK cell-based immunotherapy in hepatocellular carcinoma: An attractive therapeutic option for the next decade
Xinyi Wang, Tianye Yang, Xiaoli Shi
Cellular Signalling (2024) Vol. 124, pp. 111405-111405
Closed Access
Prognostic value of atypical B cells in breast cancer
Esmeralda García‐Torralba, Lorenzo Galluzzi, Aitziber Buqué
Trends in cancer (2024)
Closed Access
Immunogenic cell death inducers and PD-1 blockade as neoadjuvant therapy for rectal cancer
Yan Wang, Liwei Zhao, Zhen Zhang, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
Role of cyanotoxins in the development and promotion of cancer
Sandeep Rajput, Shruti Jain, Debabrata Dash, et al.
Toxicology Reports (2024) Vol. 13, pp. 101798-101798
Open Access
RIPK1 inhibition in malignant cells potentiates immunotherapy and radiotherapy outcome
Jonathan Pol, Andrea Checcoli, Manuela Lizarralde-Guerrero, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access
An Oral PROTAC Targeting HPK1 Degradation Potentiates Anti‐Solid Tumor Immunity
Yuejun Yao, Mingfei Wu, Yanfang Wang, et al.
Advanced Materials (2024)
Closed Access
A novel pharmacological entity toward integrated multimodal immunotherapy
Rafael Sirera, Manuel Beltrán‐Visiedo, Lorenzo Galluzzi
Trends in Pharmacological Sciences (2024)
Closed Access
Recombinant VSVs: A Promising Tool for Virotherapy
K A Vorona, V. D. Moroz, N. B. Gasanov, et al.
Acta Naturae (2024) Vol. 16, Iss. 4, pp. 4-14
Closed Access
A commentary on “Comparative investigation of neoadjuvant immunotherapy versus adjuvant immunotherapy in perioperative patients with cancer: a global-scale, cross-sectional, large-sample informatics study”
Jia Lin Yang, Zhongqi Wang, Haibin Deng
International Journal of Surgery (2024) Vol. 110, Iss. 9, pp. 6007-6008
Open Access
PARP7 and nucleic acid-driven oncosuppression
Flavie Naulin, Emma Guilbaud, Lorenzo Galluzzi
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 11, pp. 1177-1179
Closed Access
Methanolic Extract of Morchella esculenta (Ascomycota), Prevents Chemotherapy Related Cardiotoxicity in Tumour Bearing Mice
Sneha Das, Anjana Mathew, K. K. Janardhanan
International journal of medicinal mushrooms (2024) Vol. 27, Iss. 1, pp. 51-61
Closed Access
Neoadjuvant immunotherapy and oncolytic virotherapy in HPV positive and HPV negative skin cancer: A comprehensive review
Ali Salimi Asl, Mohsen Davari, Atousa Ghorbani, et al.
International Immunopharmacology (2024) Vol. 146, pp. 113790-113790
Closed Access

Scroll to top